CONCORD, Calif.--(BUSINESS WIRE)--Xradia, Inc. today announced the closing of a $7.0 million equity in a series D financing round. Major investors included Harris & Harris Group, Inc. an unnamed strategic investor and a prior round investor.
Xradia designs, manufactures and sells a suite of ultra high resolution 3D x-ray microscopes and fluorescence imaging systems capable of nondestructive imaging of internal structures at micrometer and nanometer scale. Important applications include 3D imaging of advanced semiconductor IC’s and packages as well as biological specimens ranging from single cells to small animals. Detailed information about Xradia can be found on its website at www.xradia.com.
Since its formation in 2000, Xradia has become recognized as the leading supplier of high performance x-ray 3D imaging solutions. The company has experienced rapid revenue growth over the last two years and achieved profitability in 2006. “This equity financing will enable the company to accelerate its penetration into new market segments while better serving its rapidly expanding semiconductor, biomedical and nanotechnology customer base. It will also enable the company to develop and introduce new, market focused products that leverage our core technologies,” commented Dr. Wenbing Yun, president, CEO, and co-founder of Xradia.
Contact: Xradia, Inc. Wenbing Yun, 925-288-1228
Source: Xradia, Inc.
